We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA OKs Third New PEP Product, J&J’s Renamed Pancreaze
FDA OKs Third New PEP Product, J&J’s Renamed Pancreaze
April 16, 2010
Johnson & Johnson (J&J) has received FDA approval for its delayed-release Pancreaze capsules for the treatment of exocrine pancreatic insufficiency.